Supplement-Related ER Diagnosis Prompts Industry Call For A Second Opinion
This article was originally published in The Tan Sheet
Executive Summary
An NEJM study, from research by a team including FDA dietary supplement program officials, concludes that 23,005 ER cases and 2,154 hospitalizations linked to supplements occur annually in the US. Trade group officials question the study’s data collection and methodology.
You may also be interested in...
Final Guidance For Reporting Adverse Events Gets Serious On Definitions
A report of emergency room treatment connected to use of a dietary supplement may not connote a serious adverse event, FDA says in the final guidance on the reporting and recordkeeping of AE information for supplements
Jurors' Answers In FTC Complaint Against Prevagen Might Form A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.